390 related articles for article (PubMed ID: 24853638)
21. Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.
Wagenvoort GH; Sanders EA; de Melker HE; van der Ende A; Vlaminckx BJ; Knol MJ
Vaccine; 2017 Mar; 35(14):1749-1757. PubMed ID: 28262334
[TBL] [Abstract][Full Text] [Related]
22. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.
Guevara M; Barricarte A; Gil-Setas A; García-Irure JJ; Beristain X; Torroba L; Petit A; Polo Vigas ME; Aguinaga A; Castilla J
Clin Microbiol Infect; 2009 Nov; 15(11):1013-9. PubMed ID: 19673968
[TBL] [Abstract][Full Text] [Related]
23. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
[TBL] [Abstract][Full Text] [Related]
24. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease.
Lai CY; Huang LM; Lee PY; Lu CY; Shao PL; Chang LY
J Microbiol Immunol Infect; 2014 Feb; 47(1):23-7. PubMed ID: 23040234
[TBL] [Abstract][Full Text] [Related]
25. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
[TBL] [Abstract][Full Text] [Related]
26. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia.
Luján M; Gallego M; Belmonte Y; Fontanals D; Vallès J; Lisboa T; Rello J
Eur Respir J; 2010 Nov; 36(5):1073-9. PubMed ID: 20150202
[TBL] [Abstract][Full Text] [Related]
27. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
[TBL] [Abstract][Full Text] [Related]
28. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
Halasa NB; Grijalva CG; Arbogast PG; Talbot TR; Craig AS; Griffin MR; Schaffner W
Pediatr Infect Dis J; 2013 Jun; 32(6):604-9. PubMed ID: 23348816
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
[TBL] [Abstract][Full Text] [Related]
30. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
[TBL] [Abstract][Full Text] [Related]
31. Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica.
Arguedas A; Abdelnour A; Soley C; Jimenez E; Jimenez AL; Ramcharran D; Porat N; Dagan R; Gray S; Rodgers GL
Vaccine; 2012 Mar; 30(13):2342-8. PubMed ID: 22300725
[TBL] [Abstract][Full Text] [Related]
32. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
33. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
Harboe ZB; Benfield TL; Valentiner-Branth P; Hjuler T; Lambertsen L; Kaltoft M; Krogfelt K; Slotved HC; Christensen JJ; Konradsen HB
Clin Infect Dis; 2010 Feb; 50(3):329-37. PubMed ID: 20047478
[TBL] [Abstract][Full Text] [Related]
34. Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era.
Vila-Corcoles A; Ochoa-Gondar O; Gomez-Bertomeu F; Raga-Luria X;
Vaccine; 2011 Oct; 29(43):7430-4. PubMed ID: 21803108
[TBL] [Abstract][Full Text] [Related]
35. Invasive pneumococcal disease in Australia, 2006.
Roche PW; Krause V; Cook H; Barralet J; Coleman D; Sweeny A; Fielding J; Giele C; Gilmour R; Holland R; Kampen R; ; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2008 Mar; 32(1):18-30. PubMed ID: 18522302
[TBL] [Abstract][Full Text] [Related]
36. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
[TBL] [Abstract][Full Text] [Related]
37. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal infections in elderly patients attending hospital since PCV-13 authorization in Spain.
Payeras A; Peñaranda M; Iñigo A; Garau M; Luis Pérez J; Gallegos C; Riera M
Infect Dis (Lond); 2017 Jan; 49(1):71-80. PubMed ID: 27686179
[TBL] [Abstract][Full Text] [Related]
39. Invasive pneumococcal disease among White Mountain Apache adults, 1991-2005.
Bliss SJ; Larzalere-Hinton F; Lacapa R; Eagle KR; Frizzell F; Parkinson A; Reid R; Craig M; Santosham M; O'Brien KL
Arch Intern Med; 2008 Apr; 168(7):749-55. PubMed ID: 18413558
[TBL] [Abstract][Full Text] [Related]
40. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]